Use of angiotensin-converting enzyme inhibitors after coronary artery bypass grafting in patients with diabetes mellitus

American Journal of Cardiology

Volumn 92, Issue 1, 2003, Pages 77-79

  Bistritz, Lana ^a   Amad, Hani ^a   Tandon, Puneeta ^a   Man, Jeremy ^a   Mullen, John C ^a   McAlister, Finlay A ^a  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; RAMIPRIL;

ADULT; AGED; ARTICLE; BIOSTATISTICS; CHI SQUARE DISTRIBUTION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HOSPITAL DISCHARGE; HUMAN; INFORMATION PROCESSING; KIDNEY ARTERY STENOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOMES RESEARCH; POSTOPERATIVE CARE; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0038538275     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00473-9     Document Type: Article

References (14)

1. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 342:2000;145-153.
2. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus results of the HOPE study and MICRO-HOPE Substudy . Lancet. 355:2000;253-259.
3. Majumdar S.R., Chang W.C., Armstrong P.W. Do the investigative sites that take part in a positive clinical trial translate that evidence into practice? Am J Med. 113:2002;140-145.
4. Lonn E.M., Yusuf S., Dzavik V., Doris I., Yi Q., Smith S., Moore-Cox A., Bosch J., Riley W.A., Teo K.K. Effects of ramipril and vitamin E on atherosclerosis. The Study to Evaluate Carotid Ultrasound changes in patients treated with Ramipril and vitamin E (SECURE). Circulation. 103:2001;919-925.
5. Kjoller-Hansen L., Steffensen R., Grande P. The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES). J Am Coll Cardiol. 35:2000;881-888.
6. Flather M.D., Yusuf S., Kober L., Pfeffer M., Hall A., Murray G., Torp-Pederson C., Ball S., Pogue J., Moye L., Braunwald E. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction a systematic overview of data from individual patients . Lancet. 355:2000;1575-1581.
7. Teo K.K., Burton J.B., Buller C.E., Plante S., Catellier D., Tymchak W., Dzavik V., Taylor D., Yokoyama S., Montague T.J. Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis. The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). Circulation. 102:2000;1748-1754.
8. Oosterga M., Voors A.A., Pinto Y.M., Buikema H., Grandjean J.G., Kingma J.H., Crijns H.J.G.M., van Gilst W.H. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). Am J Cardiol. 87:2001;542-546.
9. Warnica J.W., Van Gilst W., Baillot R., Johnstone D., Block P., Myers M.G., Chocron S., Dalle Ave S., Martineau P., Rouleau J.L. Ischemic management with accupril post bypass graft via inhibition of angiotensin converting enzyme (IMAGINE) a multicentre randomized trial - design and rationale . Can J Cardiol. 18:2002;1191-1200.
10. Allen J.K., Blumenthal R.S., Margolis S., Young D.R. Status of secondary prevention in patients undergoing coronary revascularization. Am J Cardiol. 87:2001;1203-1206.
11. Clinical reality of coronary prevention guidelines a comparison of EUROASPIRE I and II in nine countries . Lancet. 357:2001;995-1001.
12. Ayanian J.Z., Hauptman P.J., Guadagnoli E., Antman E.M., Pashos C.L., McNeil B.J. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med. 331:1994;1136-1142.
13. Ayanian J.Z., Guadagnoli E., McNeil B.J., Cleary P.D. Treatment and outcomes of acute myocardial infarction among patients of cardiologists and generalist physicians. Arch Intern Med. 157:1997;2570-2576.
14. Muhlestein J.B., Horne B.D., Blair T.L., Li Q., Madsen T.E., Pearson R.R., Anderson J.L. Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol. 87:2001;257-261.